PD-1 inhibitor (undisclosed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 inhibitor (undisclosed), covering 2025-12-26 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial [Phase 2]